Orsema 0.25mg Subcutaneous Injection | Pre-Filled Syringe | ePharma
0 Items
0

Leading Online Pharmacy, of Bangladesh

Home Diabetic Care Insulin Pen (Onetime) Orsema 0.25mg Subcutaneous Injection
thumbnail
thumbnail
thumbnail


✔ 100% Authentic Product


Offer

Orsema 0.25mg Subcutaneous Injection

Generic: Semaglutide

Type: Injection

Pack Size: 1 Pc

Semaglutide is used in the treatment of type 2 diabetes mellitus.


How to Order

🛒 How to order this item?

Discount Price: ৳ 325.5
MRP: ৳ 350 7% Off

⪼ Save  ৳: 24.5  in this Product


100% Genuine Products, Guaranteed

Safe & Secure Payments, Always

Fast, Secure & Efficient Delivery

Proper Packaging



Cashback offer(Optional):

  • 🏷 Coupon CASH55 ✔️ Get ৳55 back - for Ordering ৳500+
  • 🏷 Coupon CASH120 ✔️ Get ৳120 back - for Ordering ৳1200+
  • 🏷 Coupon CASH200 ✔️ Get ৳200 back - for Ordering ৳2500+
  • 🏷 Coupon CASH300 ✔️ Get ৳300 back - for Ordering ৳3500+
  • 🏷 Coupon CASH400 ✔️ Get ৳400 back - for Ordering ৳4500+
  • 🏷 Coupon CASH500 ✔️ Get ৳500 back - for Ordering ৳5500+
  • 🔹 Delivery charge is applicable for Cashback offer
  • 🔹 Foreign manufacturer products are not applicable for Cashback offer

  • Cash on Delivery - All over Bangladesh
  • Urgent Delivery - 2 Hours Dhaka City

  • ফ্রি ডেলিভারি! - ১৪৯৯ টাকা+ অর্ডারে ঢাকা শহরে ।
  • ফ্রি ডেলিভারি! - ২৯৯৯ টাকা+ অর্ডারে ঢাকার বাহিরে ।

✅ Description:

Orsema 0.25mg is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. Additionally, it is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m² or greater (Obesity) or 27 kg/m² or greater (Overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

Safety Advices


Alcohol
UNSAFE

It is not known whether it is safe to consume alcohol with Orsema 0.25mg Subcutaneous Injection. Please consult your doctor.


Pregnancy
CONSULT YOUR DOCTOR

Orsema 0.25mg Subcutaneous Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.


Breastfeeding
CONSULT YOUR DOCTOR

Information regarding the use of Orsema 0.25mg Subcutaneous Injectionduring breastfeeding is not available. Please consult your doctor.


Driving
CAUTION

It is not known whether Orsema 0.25mg Subcutaneous Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.


Kidney
SAFE IF PRESCRIBED

Orsema 0.25mg Subcutaneous Injection is safe to use in patients with kidney disease. No dose adjustment of Orsema 0.25mg Subcutaneous Injection is recommended.


Liver
SAFE IF PRESCRIBED

Orsema 0.25mg Subcutaneous Injection is safe to use in patients with liver disease. No dose adjustment of Orsema 0.25mg Subcutaneous Injection is recommended.

Similar Products

✔️ Uses of Orsema 0.25mg Subcutaneous Injection

Type II Diabetes mellitus.

✔️ Side Effects of Orsema 0.25mg Subcutaneous Injection

It is not known if Orsema 0.25 mg will cause thyroid tumors or medullary thyroid carcinoma (MTC) in people. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

✔️ Pediatric Uses:

Safety and efficacy not established in pediatric patients.

✔️ Geriatric Use:

No overall differences in safety or efficacy were detected between geriatric patients and younger patients.

✔️ Renal Impairment:

No dose adjustment is recommended.

✔️ Hepatic Impairment:

No dose adjustment is recommended.

✔️ Pharmacology

Orsema 0.25 mg is a GLP-1 analogue with 94% sequence homology to human GLP-1. It acts as a GLP-1 receptor agonist, stimulating insulin secretion, lowering glucagon secretion, and delaying gastric emptying in a glucose-dependent manner.

✔️ Dosage & Administration of Orsema 0.25mg Subcutaneous Injection

Subcutaneous injection:

  • The starting dose: 0.25 mg Orsema 0.25 mg once weekly for 4 weeks subcutaneously.
  • Dose Escalation:
    • Week 1 through 4: 0.25 mg
    • Week 5 through 8: 0.5 mg
    • Week 9 through 12: 1 mg
    • Week 13 through 16: 1.7 mg
  • Maintenance dose: Week 17 and onwards: 2.4 mg

In the event of an overdose, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms.

✔️ Interaction

Initiating Orsema 0.25 mg concomitant with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia. Caution should be exercised when oral medications are concomitantly administered with Orsema 0.25 mg.

✔️ Contraindications

Orsema 0.25 mg is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) and hypersensitivity to Orsema 0.25 mg.

✔️ Pregnancy & Lactation

Limited data are available. Use during pregnancy or breastfeeding only if the potential benefit justifies the potential risk.

✔️ Precautions & Warnings
  • Risk of Thyroid C-Cell Tumors.
  • Pancreatitis.
  • Diabetic Retinopathy Complications.
  • Never Share Orsema 0.25 mg Pen Between Patients.
  • Hypoglycemia with Concomitant Use of Insulin.
  • Acute Kidney Injury.
  • Hypersensitivity.
✔️ Storage Conditions

Store your Orsema 0.25mg Subcutaneous Injection in the refrigerator at 2°C to 8°C (36°F to 46°F).

Frequently Asked Questions (FAQ)

A: While Orsema 0.25 is approved by the FDA for the management of type 2 diabetes, it has not received formal approval as a chronic weight management aid. Nevertheless, studies have demonstrated that when combined with a nutritious diet and consistent exercise, Orsema 0.25 can result in weight loss for patients.

A: Eat slowly and take smaller meals. Eat foods that are light and bland. Drink clear or ice-cold drinks (like water or unsweetened tea). Avoid fried, greasy, or sweet foods. It is important that you continue with your diet and exercise plan as told by your doctor.

A: Take Orsema 0.25 as advised by your physician. It should be taken on an empty stomach. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your physician will fix the correct dose and frequency for you based on your age, body weight, and disease condition.

A: If you forget to take a dose of Orsema 0.25, skip the missed dose and just take your normal dose the next day. Do not take a double dose to make up for a missed dose.

A: Take this medicine at least 30 minutes before the first food, drink, or other oral medicines of the day with a glass of water. After taking Orsema 0.25 wait at least 30 minutes before having your first meal or drink of the day or taking other oral medicines.

A: Do not stop taking the medicine abruptly as stopping the medicine may increase the blood sugar levels. Complete the full course of management even if you feel better.

A: Orsema 0.25 belongs to a class of medicines called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists) which helps the body to make more insulin when your blood sugar is high.

A: The common side effects of taking Orsema 0.25 are nausea, diarrhea, and low blood sugar (signs include cold sweats, cool pale skin, headache, fast heartbeat, nausea or hunger, changes in vision). Contact your doctor if any of the symptoms worsen.

A: Orsema 0.25 is used in the management of type 2 diabetes when diet and exercise are not enough to control blood sugar levels.
Ratings & Reviews

No review

Check our pricing section for Orsema 0.25mg Subcutaneous Injection price in Bangladesh. After Submitting Order, You will receive a phone call for verification, price and delivery confirmation. We deliver inside/outside Dhaka (Delivery all over Bangladesh). We offer express/urgent medicine delivery inside Dhaka. Do not forget to check discount/cashback offers if you are eligible to avail any.

Disclaimer:
ePharma sole intention is to ensure that its consumers get proper information as musch as possible. Although we do not guarantee the accuracy and the completeness of the information that provided and here information is for informational purposes only. The information contained herein should NOT be used as a substitute for the advice of a qualified physician. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your healthcare professional and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Pricing Information, Availability:
ePharma reserves the right to make adjustments to pricing, Products and Service offerings for reasons including, but not limited to, changing market conditions, Product discontinuation, Product unavailability, manufacturer price changes, supplier price changes and errors in advertisements. All orders are subject to Product availability and the availability of Personnel to perform the Services. Therefore, Seller cannot guarantee that it will be able to fulfill Customer’s orders. If Services are being performed on a time and materials basis, any estimates provided by Seller are for planning purposes only.

Hi, there!



Get more features!

Download the app now

  • Pill reminder
  • Prescription & Report
  • Doctor consultation
  • 24/7 helpline